Friday Five

COVID-19 vaccine, NHS test and trace programme and mental health on the rise – This Week’s Friday Five

Data indicates Pfizer and BioNTech’s COVID-19 vaccine is 90% effective Early data suggests that American pharma giant Pfizer and Germany-headquartered BioNTech have developed a potential COVID-19 vaccine resulting in 90% effectiveness. The phase III trial of Pfizer and BioNTech’s COVID-19 vaccine candidate – named BNT162b2 – involved 43,538 individuals, who received two doses of the…